The guidelines state that clinicians should offer blue light cystoscopy, if available, as an adjunct to traditional white light cystoscopy (WLC) to increase tumor detection and decrease recurrence.

Cystoscopy without the aid of urinary markers is the most cost-effective strategy for detecting recurrence of non-invasive bladder cancer, according to researchers. In a study that examined five ...

COLUMBIA, Md.--(BUSINESS WIRE)--Ambu Inc., the world leader in single-use endoscopes, announced today that it has been awarded a contract with UroGPO, the largest Group Purchasing Organization for ...

ORANGEBURG, N.Y., May 13, 2011 (GLOBE NEWSWIRE) -- Vision-Sciences, Inc. (Nasdaq:VSCI) announced today the introduction by Stryker Corporation ("Stryker") of the new line of EndoSheath Cystoscopy ...

Rocky River, Ohio-based UroGPO entered into a contract with Ambu for a single-use endoscope. UroGPO has a three-year agreement in line for the Ambu aScope 4 Cysto and aView 2 Advance HD Monitor, ...

Ambu Inc., a rapidly growing medical device maker and pioneer of sterile, single-use endoscopes, announced today that it has received Health Canada clearance for the aScopeTM 4 Cysto, the company’s ...

Bladder biopsy of normal-looking mucosa, as determined by cystoscopy, might not add clinical value in patients with positive voided-urine cytology after treatment of non-muscle-invasive bladder cancer ...

Hexvix /Cysview and BLC are registered trademarks of Photocure ASA. Saphira is a registered trademark of KARL STORZ Endoscopy. This press release may contain product ...

CystoSmart operates with white light cystoscopy to support detection accuracy in real-time and through post-processing.

COLUMBIA, Md.--(BUSINESS WIRE)--Ambu Inc., a rapidly growing medical device maker and pioneer of sterile, single-use endoscopes, announced today that it has received Health Canada clearance for the ...